Related references
Note: Only part of the references are listed.Quality of life in primary aldosteronism: A prospective observational study
Fabrizio Buffolo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans A Retrospective Cohort Study
Jordana B. Cohen et al.
ANNALS OF INTERNAL MEDICINE (2021)
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
Heather Wachtel et al.
CURRENT CARDIOLOGY REPORTS (2021)
Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort Study
Yen Kheng Tan et al.
ENDOCRINE CONNECTIONS (2021)
Tolerability and Efficacy of Long-Term Medical Therapy in Primary Aldosteronism
Fengjie Tang et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Patient-centered care in Israeli IVF units: divergent perceptions of patients and providers
Tamar R. Medina-Artom et al.
ISRAEL JOURNAL OF HEALTH POLICY RESEARCH (2020)
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
W. F. Young
JOURNAL OF INTERNAL MEDICINE (2019)
Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
Lukas Engler et al.
ENDOCRINE CONNECTIONS (2019)
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
Gregory L. Hundemer et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
Silvia Monticone et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Links between blood pressure and medication intake, well-being, stress, physical activity and symptoms reported via a mobile phone-based self-management support system: a cohort study in primary care
Charles Taft et al.
BMJ OPEN (2018)
Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment
Marieke Velema et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review
Marieke S. Velema et al.
HORMONE AND METABOLIC RESEARCH (2017)
Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000-2015)
Ermanno Rossi et al.
JOURNAL OF HYPERTENSION (2017)
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Tracy A. Williams et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Continuity of care: still important in modern-day general practice
Holly Jeffers et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2016)
Guidelines for primary aldosteronism: uptake by primary care physicians in Europe
Paolo Mulatero et al.
JOURNAL OF HYPERTENSION (2016)
Health literacy and adherence to medical treatment in chronic and acute illness: A meta-analysis
Tricia A. Miller
PATIENT EDUCATION AND COUNSELING (2016)
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension
Shusuke Yagi et al.
HYPERTENSION RESEARCH (2011)
Quality of Life in Patients with Bilateral Primary Aldosteronism before and during Treatment with Spironolactone and/or Amiloride, Including a Comparison with Our Previously Published Results in Those with Unilateral Disease Treated Surgically
Ashraf H. Ahmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Psychological Assessment of Primary Aldosteronism: A Controlled Study
Nicoletta Sonino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Continuous Activation of Renin-Angiotensin System Impairs Cognitive Function in Renin/Angiotensinogen Transgenic Mice
Shinji Inaba et al.
HYPERTENSION (2009)
Quality of life: patients and doctors don't always agree: a meta-analysis
AJ Janse et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
The brain mineralocorticoid receptor: greedy for ligand, mysterious in function
JMHM Reul et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)